Target Price | $42.93 |
Price | $40.44 |
Potential | 6.17% |
Number of Estimates | 15 |
15 Analysts have issued a price target Exelon 2026 . The average Exelon target price is $42.93. This is 6.17% higher than the current stock price. The highest price target is $47.00 16.22% , the lowest is $39.00 3.56% . | |
A rating was issued by 21 analysts: 6 Analysts recommend Exelon to buy, 14 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Exelon stock has an average upside potential 2026 of 6.17% . Most analysts recommend the Exelon stock at Hold. |
12 Analysts have issued a sales forecast Exelon 2024 . The average Exelon sales estimate is $21.7b . This is 5.31% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $23.0b 0.52% , the lowest is $19.9b 13.29% .
This results in the following potential growth metrics:
2023 | $21.7b | 13.89% |
---|---|---|
2024 | $21.7b | 0.09% |
2025 | $22.5b | 3.48% |
2026 | $23.2b | 3.17% |
2027 | $23.2b | 0.12% |
2028 | $24.2b | 4.16% |
9 Analysts have issued an Exelon EBITDA forecast 2024. The average Exelon EBITDA estimate is $8.3b . This is 5.23% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $8.5b 8.25% , the lowest is $7.9b 0.63% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | $7.5b | 9.65% |
---|---|---|
2024 | $8.3b | 9.68% |
2025 | $8.8b | 6.58% |
2026 | $9.4b | 6.90% |
2027 | $10.1b | 6.64% |
2028 | $11.0b | 9.64% |
2023 | 34.74% | 3.72% |
---|---|---|
2024 | 38.14% | 9.79% |
2025 | 39.28% | 2.99% |
2026 | 40.70% | 3.62% |
2027 | 43.35% | 6.51% |
2028 | 45.63% | 5.26% |
6 Exelon Analysts have issued a net profit forecast 2024. The average Exelon net profit estimate is $2.5b . This is 1.21% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.5b 2.47% , the lowest is $2.5b 0.63% .
This results in the following potential growth metrics and future Net Margins:
2023 | $2.4b | 6.36% |
---|---|---|
2024 | $2.5b | 5.11% |
2025 | $2.7b | 7.22% |
2026 | $2.8b | 5.05% |
2027 | $3.0b | 6.67% |
2028 | $3.1b | 5.63% |
2023 | 10.82% | 6.60% |
---|---|---|
2024 | 11.39% | 5.23% |
2025 | 11.80% | 3.60% |
2026 | 12.01% | 1.78% |
2027 | 12.80% | 6.58% |
2028 | 12.98% | 1.41% |
6 Analysts have issued a Exelon forecast for earnings per share. The average Exelon <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $2.46 . This is 1.23% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $2.49 2.47% , the lowest is $2.45 0.82% .
This results in the following potential growth metrics and future valuations:
2023 | $2.34 | 6.36% |
---|---|---|
2024 | $2.46 | 5.13% |
2025 | $2.64 | 7.32% |
2026 | $2.77 | 4.92% |
2027 | $2.96 | 6.86% |
2028 | $3.12 | 5.41% |
Current | 16.24 | 0.43% |
---|---|---|
2024 | 16.03 | 1.29% |
2025 | 14.95 | 6.74% |
2026 | 14.23 | 4.82% |
2027 | 13.34 | 6.25% |
2028 | 12.63 | 5.32% |
Based on analysts' sales estimates for 2024, the Exelon stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 3.89 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 1.82 .
This results in the following potential growth metrics and future valuations:
Current | 3.69 | 0.27% |
---|---|---|
2024 | 3.89 | 5.51% |
2025 | 3.76 | 3.37% |
2026 | 3.65 | 3.07% |
2027 | 3.64 | 0.12% |
2028 | 3.50 | 3.99% |
Current | 1.73 | 4.17% |
---|---|---|
2024 | 1.82 | 5.61% |
2025 | 1.76 | 3.36% |
2026 | 1.71 | 3.07% |
2027 | 1.71 | 0.12% |
2028 | 1.64 | 3.99% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.